KDP categories · Top KDP authors
Roselyn Andrew: Amazon KDP author data
As of Nov 6, 2026, Roselyn Andrew has 3 books on Amazon, 3 of them on a best-seller list in the last 30 days (best rank #10), mostly in Nurse-Patient Relations, Clinical, Medical Informatics.
| Median price | $20.97 |
|---|---|
| Price range (middle 50%) | $15.48 – $21.92 |
| Median reviews | 1 |
| Total reviews | 5 |
| New books (30 days) | 3 |
| Breakout books (30 days) | 3 |
What stands out
- 3 new books in the last 30 days, 3 of them broke into a Best Sellers list.
Roselyn Andrew's best-ranked books
-
Fenbendazole & Ivermectin Protocols for Cancer: A Caregiver Organizer for Repurposed Drug Protocols, with Sourcing Verification, Symptom Tracking Logs, and Doctor Conversation Scripts
by Roselyn Andrew
- Price$20.97
- Rating5.0
- Reviews3
- Published2026-08
-
The No-Secret Chart Approach to Protect Your License: A Practical Clinical Guide to Nursing Documentation, Charting Examples, and Essential Templates to Help Nurses & NPs Avoid Charting Mistakes
by Roselyn Andrew
- Price$9.99
- Rating5.0
- Reviews1
- Published2026-08
-
The No-Secret Chart Approach to Protect Your License: A Practical Clinical Guide to Nursing Documentation, Charting Examples, and Essential Templates to Help Nurses & NPs Avoid Charting Mistakes
by Roselyn Andrew
- Price$22.87
- Rating5.0
- Reviews1
Main categories
FAQ
How many books does Roselyn Andrew have on Amazon?
KDPTop tracks 3 of their books; 3 made an Amazon list in the last 30 days.
Which categories does Roselyn Andrew publish in?
Their books chart most often in Nurse-Patient Relations, Clinical, Medical Informatics.
How does Roselyn Andrew price their books?
The median price is $20.97; half of the books cost $15.48–$21.92.
Has Roselyn Andrew released new books recently?
3 new books in the last 30 days, 3 of which reached a Best Sellers list.
About this data
Data comes from KDPTop's daily crawl of Amazon's public Best Sellers pages; medians use the latest list. The opportunity score (0–100, higher is easier to enter) combines the review barrier, the share of low-review books, list turnover, new-release share and price.